-
公开(公告)号:EP4370921A1
公开(公告)日:2024-05-22
申请号:EP22842956.9
申请日:2022-07-15
申请人: Cypre, Inc.
发明人: HRIBAR, Kolin , XUE, Bin
CPC分类号: G01N33/5091 , G01N33/5082 , G01N2800/702820130101 , C12N2533/9020130101 , C12N2502/132320130101 , C12N5/0693 , C12N2513/0020130101 , A61P35/00 , A61K39/4615 , A61K39/4611 , A61K39/4614 , A61K39/4612 , A61K39/4622 , A61K39/4613 , A61K39/4644
-
公开(公告)号:EP4408983A1
公开(公告)日:2024-08-07
申请号:EP22793544.2
申请日:2022-09-22
发明人: FEJER, Gyorgy , LOPATECKA, Justyna
IPC分类号: C12N5/0786
-
公开(公告)号:EP4309739A3
公开(公告)日:2024-04-17
申请号:EP23214393.3
申请日:2018-01-26
发明人: Shen, Haifa
CPC分类号: A61K9/1271 , A61K2039/5320130101 , A61K2039/5553320130101 , A61K2039/5555520130101 , A61K47/645 , A61K47/6925 , A61K9/0019 , A61K9/0021 , A61P35/00 , A61K39/39 , A61K39/46449 , A61K39/4614 , A61K39/4622 , A61K39/4612 , A61K39/4615 , A61K39/464406
摘要: Disclosed are biocompatible core/shell compositions suitable for the delivery of populations of mRNA molecules to mammalian cells. The disclosed core-shell structured multicomponent compositions are optimized for the delivery of mRNAs encoding one or more cancer- or tumor-specific antigens to a population of antigen presenting cells, including, for example, human dendritic cells, macrophages and B cells. Also disclosed are methods for use of these compositions as therapeutic cancer vaccines.
-
公开(公告)号:EP3986428B9
公开(公告)日:2024-08-28
申请号:EP20733317.0
申请日:2020-06-22
IPC分类号: A61K35/17 , C07K14/725
-
5.
公开(公告)号:EP4388082A1
公开(公告)日:2024-06-26
申请号:EP22859230.9
申请日:2022-08-19
CPC分类号: A61P25/28 , C12N5/0645 , C12N2506/4520130101 , C12N2533/9020130101 , C12N2501/11520130101 , C12N2501/12520130101 , C12N2501/16520130101 , C12N2501/14520130101 , C12N2501/1520130101 , C12N2501/15520130101 , C12N2501/230320130101 , C12N2501/2220130101 , C12N2501/2620130101 , A61K39/46433 , A61K39/4622 , A61K2239/3820230501 , A61K39/4621 , A61K39/46432 , A61K39/4614
-
公开(公告)号:EP3986428B1
公开(公告)日:2024-05-29
申请号:EP20733317.0
申请日:2020-06-22
IPC分类号: A61K35/17 , C07K14/725
-
公开(公告)号:EP4423251A1
公开(公告)日:2024-09-04
申请号:EP22888380.7
申请日:2022-10-18
发明人: LIU, Yuan , BIAN, Zhen , SHI, Lei , ZEN, Ke , KIDDER, Koby
IPC分类号: C12N5/0786 , A61K31/739 , A61K35/15 , A61K35/17 , A61K38/21
CPC分类号: A61K35/15 , A61K35/17 , C12N5/0645 , C12N2502/111420130101 , A61K45/06 , A61P35/00 , A61K39/4614 , A61K39/464401 , A61K39/4644
-
公开(公告)号:EP4406544A2
公开(公告)日:2024-07-31
申请号:EP24167623.8
申请日:2016-06-22
申请人: Cellis AG
IPC分类号: A61K35/15
CPC分类号: A61K38/42 , C12N5/0645 , A61K51/1203 , A61K38/40 , A61K47/64 , A61K47/644 , A61K47/6445 , A61K47/6901 , C12N5/0636 , C12N5/0642 , A61P1/04 , A61P1/18 , A61P11/00 , A61P13/10 , A61P15/00 , A61P17/02 , A61P27/02 , A61P29/00 , A61P31/00 , A61P35/00 , A61P35/04 , A61P37/02 , A61P43/00 , A61P9/10 , A61K2239/3820230501 , A61K39/4622 , C12N5/0646 , A61K2239/5020230501 , A61K39/4614 , A61K2239/3120230501 , A61K39/4644
摘要: The present invention relates to an isolated cellular targeted delivery system comprising a CD45+ leukocyte cell comprising within said cell a complex of one or more iron binding proteins and an active ingredient as well as methods for producing such isolated cellular targeted delivery system and uses of such system for therapy, in particular for therapy of cancer.
-
公开(公告)号:EP4335444A3
公开(公告)日:2024-06-26
申请号:EP23211804.2
申请日:2018-01-17
申请人: BioNTech SE , University Of Verona
IPC分类号: C12N5/0786 , A61K35/15 , A61K35/28 , C07K14/435 , C12N5/0775 , A61K48/00 , A61K35/12
CPC分类号: A61K48/00 , A61K35/28 , C12N5/0645 , C12N5/0663 , A61K2035/12220130101 , A61K2035/12420130101 , C12N2510/0020130101 , C07K14/4702 , A61K39/461 , A61K39/4621 , A61K39/4614 , A61K2239/3120230501 , A61K39/4622 , A61K2239/3820230501 , A61K39/46434
摘要: The present invention relates to cells which are engineered so as to increase the cellular level of cellular FLICE [Fas-associated death domain (FADD)-like IL-1β-converting enzyme]-inhibitory protein (CFLAR). The engineered cells have the ability to induce tolerance. Enhanced tolerogenicity is useful for prolonging survival of a foreign transplant and for treatment of autoimmune diseases.
-
公开(公告)号:EP4436615A1
公开(公告)日:2024-10-02
申请号:EP22899577.5
申请日:2022-11-28
-
-
-
-
-
-
-
-
-